Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-1,100
Closed -$64K 7067
2018
Q4
$64K Buy
1,100
+700
+175% +$43.9K ﹤0.01% 5336
2018
Q3
$26K Buy
+400
New +$26.5K ﹤0.01% 6374
2017
Q4
Sell
-2,100
Closed -$135K 6954
2017
Q3
$135K Buy
+2,100
New +$136K ﹤0.01% 4716
2015
Q1
Sell
-4,600
Closed -$212K 7107
2014
Q4
$212K Sell
4,600
-12,000
-72% -$562K ﹤0.01% 4581
2014
Q3
$747K Sell
16,600
-12,600
-43% -$590K ﹤0.01% 3605
2014
Q2
$1.34M Buy
29,200
+11,900
+69% +$560K ﹤0.01% 3042
2014
Q1
$795K Buy
17,300
+15,800
+1,053% +$691K ﹤0.01% 3491
2013
Q4
$62K Buy
+1,500
New +$59K ﹤0.01% 6025
2013
Q3
Sell
-800
Closed -$30K 7449
2013
Q2
$30K Buy
+800
New +$28.6K ﹤0.01% 6622

Other funds holding DOX

Barclays's DOX Position: Q1 2026 in Review

Barclays reduced its Amdocs (DOX) stake by 33% in Q1 2026, selling an estimated $5.85M and leaving 164,130 shares worth $10.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1416.

Barclays first reported a position in DOX in Q2 2013 and has held it in 51 quarters since. The position peaked at $30.2M in Q1 2024. 474 funds tracked by Wall St. Rank hold DOX as of Q1 2026.

  • Barclays held 164,130 shares of Amdocs worth $10.7M as of Q1 2026.
  • Barclays sold 79,987 Amdocs shares in Q1 2026, an estimated $5.85M.
  • Amdocs made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #1416 holding.
  • Barclays first reported a position in Amdocs in Q2 2013 and has held it in 51 quarters since.
  • Barclays's Amdocs position peaked at $30.2M in Q1 2024.
  • 474 funds tracked by Wall St. Rank held Amdocs as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.